HOME >> BIOLOGY >> NEWS
New clues to hereditary blinding disease found

HANOVER, NH Seeking a cure for an inherited disease that causes blindness in over one million people worldwide, Dartmouth Medical School researchers have discovered a critical role for zinc in retinitis pigmentosa. The amount of zinc, a trace metal naturally absorbed by the body, can determine whether a key protein for vision functions normally or misfolds, they found.

An inability to successfully bind zinc to rhodopsin, a light receptor protein in the eye, can trigger retinitis pigmentosa (RP), a degenerative disease that leaves many patients legally blind by the age of 40. The findings parallel similar progress in harnessing essential trace metals in the body to treat several neurodegenerative diseases including Alzheimer's, Parkinson's and Lou Gehrig's Disease.

The research, appearing as the "Paper of the Week" in the August 20 issue of the Journal of Biological Chemistry (JBC), is the first confirmation that zinc is present and plays a significant role in the normal folding and functions of rhodopsin, and if defective, leads to retinal degeneration.

"We have found if there is not enough zinc in the body or there is a mutation in the zinc binding site, the protein rhodopsin will misfold and break down, triggering cell death, degeneration of the retina and eventually blindness," said John Hwa, MD, PhD, assistant professor of pharmacology and toxicology at Dartmouth Medical School. "What is especially exciting about this new direction in our research is that this characteristic of rhodopsin is very similar to other proteins implicated in many neurodegenerative and human diseases. The fact that a trace metal can have such a critical impact on rhodopsins ability to function properly may point to significant advances for research in other devastating illnesses as well."

The principles of the protein rhodopsin may be extended to its relatives: G-protein coupled receptors that mediate numerous functions in the body including sight,
'"/>

Contact: Andy Nordhoff
mednews@dartmouth.edu
603-650-1492
Dartmouth Medical School
18-Aug-2004


Page: 1 2

Related biology news :

1. University of Alberta researcher looks for clues to mysterious disease
2. Broken arms and collateral damage: clues to predator-driven evolution
3. Researchers find clues about how antibodies specialize
4. Genetic clues found for common congenital brain disorder
5. Heartless worms hold clues to cardiac arrhythmias, sudden death
6. Small animal imaging gives cancer clues
7. Lake research offers clues to managing crayfish invasions
8. Volcanic soils yield new clues about the emergence of powerful chiefdoms in Hawaii
9. Damaged genes in aging human brain provide clues to cognitive decline
10. Two dinosaurs from Africa give clues to continents split
11. From algae, weeds and people: new genetic clues to complex obesity syndrome

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/13/2020)... ... June 11, 2020 , ... Bode Technology (Bode), ... forensic genealogy team. Bode’s Forensic Genealogy Service (FGS) continues to deliver ... analysis methods. The team has added experienced genealogists, each having over a decade ...
(Date:6/11/2020)... ... June 09, 2020 , ... Superior Controls, Inc. , an E Technologies ... for the life sciences industry, is pleased to announce the recent hiring of Ray ... company’s Seabrook, New Hampshire office. In his new role, Boudreau will use his ...
(Date:6/5/2020)... ... June 04, 2020 , ... “Although we are disappointed to have to ... attendees, staff, and the public. We remain committed to creating a global platform ... virtually,” said Julie Sutcliffe, President of WMIS. , The abstract deadline ...
Breaking Biology News(10 mins):
(Date:7/1/2020)... WESTMINSTER, Colo. (PRWEB) , ... ... ... providers of expert tissue data insights, today announced that the launch of ... PD-L1 results along with data about the tumor microenvironment (TME). , “Flagship’s ...
(Date:6/28/2020)... ... June 25, 2020 , ... Lumeda ... treating cancer, today announced the company has entered a license agreement with Roswell ... provides Lumeda globally exclusive rights to Roswell Park intellectual property surrounding a novel ...
(Date:6/23/2020)... ... June 23, 2020 , ... DeCurtis Corporation, the ... today that Derek Fournier has been appointed CEO and President. Founder and former ... immediately. , “DeCurtis Corporation has been on an incredible journey for the ...
(Date:6/23/2020)... Ore. (PRWEB) , ... June 23, 2020 , ... ... of innovative CNS therapies, today announced that it has filed an Investigational New ... a Phase 2b clinical trial of its lead drug candidate NBTX-001 in patients ...
Breaking Biology Technology:
Cached News: